Llwytho...
The role of nutraceuticals for the treatment of non‐alcoholic fatty liver disease
Non‐alcoholic fatty liver disease (NAFLD) represents the most common chronic liver disease. It is characterized by a wide spectrum of hepatic changes, which may progress to liver fibrosis and to cirrhosis. NAFLD is considered as the hepatic component of the metabolic syndrome but mechanisms underlyi...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Br J Clin Pharmacol |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley and Sons Inc.
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5338137/ https://ncbi.nlm.nih.gov/pubmed/26852185 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12899 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|